Drug formulators should consider the physical properties of their products during pharmaceutical drug development. The physical properties of a solid drug substance are highly dependent on the solid form. It is critical to understand the solid form landscape and select the optimum solid form for drug performance, stability and manufacturability as early in the development process as possible. Join this free webinar to learn about different solid forms (polymorph and salt) and different technologies to achieve these forms (cocrystal and dispersion).View webinar
More from Curia
When a drug substance requires a parenteral formulation to administer it, there are key factors to consider when choosing the ideal CDMO partner.